InspireMD (NSPR) Cash from Investing Activities (2010 - 2025)
InspireMD (NSPR) posted quarterly Cash from Investing Activities of -$45.1 million for Q4 2025, down 647.62% year-over-year from $8.2 million in Q4 2024, and down 697.74% quarter-over-quarter from $7.6 million in Q3 2025.
InspireMD (NSPR) Cash from Investing Activities (2010 - 2025) Analysis & Trends
InspireMD's Cash from Investing Activities history runs 16 years deep, the most recent figure standing at -$45.1 million for Q4 2025.
- In Q4 2025, Cash from Investing Activities fell 647.62% year-over-year to -$45.1 million; the TTM figure through Dec 2025 stood at -$30.6 million (down 341.75% YoY), while the FY2025 annual figure was -$30.6 million, down 341.75% from the prior year.
- Cash from Investing Activities for Q4 2025 stood at -$45.1 million, down from $7.6 million in the prior quarter.
- The five-year high for Cash from Investing Activities was $8.2 million in Q4 2024, with the low at -$45.1 million in Q4 2025.
- The 5-year median for Cash from Investing Activities is $1.9 million (2021), against an average of -$2.4 million.
- The sharpest annual moves came in 2021 and 2024: Cash from Investing Activities sank 49255.1% in 2021, then surged 22994.44% in 2024.
- InspireMD's Cash from Investing Activities stood at $1.8 million in 2021, then soared by 111.08% to $3.9 million in 2022, then tumbled by 100.93% to -$36000.0 in 2023, then soared by 22994.44% to $8.2 million in 2024, then sank by 647.62% to -$45.1 million in 2025.
- Business Quant data shows NSPR's Cash from Investing Activities at -$45.1 million in Q4 2025, $7.6 million in Q3 2025, and $5.3 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | -673.00 Mn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | -639.00 Mn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | -917.00 Mn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | -1.96 Bn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | -193.20 Mn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | 329.80 Mn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | -115.00 Mn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | -22.08 Mn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | -108.50 Mn |
| 10 | InspireMD | 57.25 Mn | 3.04 Mn | 1.18 Mn | -45.14 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -45.14 Mn |
| Dec 31, 2025 | -45.14 Mn |
| Sep 30, 2025 | 7.55 Mn |
| Sep 30, 2025 | 7.55 Mn |
| Jun 30, 2025 | 5.32 Mn |
| Jun 30, 2025 | 5.32 Mn |
| Mar 31, 2025 | 1.70 Mn |
| Mar 31, 2025 | 1.70 Mn |
| Dec 31, 2024 | 8.24 Mn |
| Dec 31, 2024 | 8.24 Mn |
| Sep 30, 2024 | -5.92 Mn |
| Sep 30, 2024 | -5.92 Mn |
| Jun 30, 2024 | 5.51 Mn |
| Jun 30, 2024 | 5.51 Mn |
| Mar 31, 2024 | 4.82 Mn |
| Mar 31, 2024 | 4.82 Mn |
| Dec 31, 2023 | -36,000.00 |
| Dec 31, 2023 | -36,000.00 |
| Sep 30, 2023 | 6.39 Mn |
| Sep 30, 2023 | 6.39 Mn |